Potential biological markers for the staging of tumor progression in oral mucosa: A multivariate analysis

被引:5
|
作者
Kannan, S
Chandran, GJ
Balaram, P
Chidambaram, S
Nair, MK
机构
[1] CONSULTING ACTUARY,THIRUVANANTHAPURAM,KERALA,INDIA
[2] REG CANC CTR,DIV RADIAT ONCOL,THIRUVANANTHAPURAM,KERALA,INDIA
来源
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 1996年 / 11卷 / 02期
关键词
tumor progression; biomarkers; biological staging; oral mucosa; oral cancer; cytoskeletal proteins; ras p21; EGFR; EGF;
D O I
10.1177/172460089601100202
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A recent trend in cancer control programmes is the development of early detection strategies and chemoprevention of premalignant lesions. The present study evaluates the potential of selected markers in the biological staging of tumor progression in oral mucosa for better management of the disease. The expression patterns of various cytokeratin protein types such as 10/11, 13 & 16, 19, 18, 14 and pancytokeratin, involucrin, ras p21, epidermal growth factor (EGF) and its receptor (EGFR) were assessed immunohistochemically in various stages of tumor progression in oral mucosa. Statistical analyses such as the Kruskal-Wallis one-way ANOVA, Spearman's rank correlation and multiple regression analysis were carried out to see which proteins have a significant association with tumor progression in oral mucosa.-Statistical analysis showed that the expression patterns of cytokeratin types 10/11, 14 and 19, involucrin and epidermal growth factor were significantly correlated with tumor progression in oral mucosa in both univariate and multivariate analysis. Thus the biological stage of a lesion can be calculated from the multiple regression equation derived for these proteins, which could be more useful in assessing the stage of tumor progression in oral mucosa than histopathological grading.
引用
收藏
页码:67 / 76
页数:10
相关论文
共 50 条
  • [41] Bioinformatics Analysis Identifies Molecular Markers Regulating Development and Progression of Endometriosis and Potential Therapeutic Drugs
    Peng, Ying
    Peng, Cheng
    Fang, Zheng
    Chen, Gang
    FRONTIERS IN GENETICS, 2021, 12
  • [42] Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients
    Lawicki, S.
    Bedkowska, G. E.
    Wojtukiewicz, M.
    Szmitkowski, M.
    ADVANCES IN MEDICAL SCIENCES, 2013, 58 (02): : 207 - 215
  • [43] Tissue transcriptome profiling and pathway analyses revealed novel potential biomarkers in the tumor progression of canine oral melanoma
    Pisamai, Sirinun
    Edwards, Steven W.
    Cheng, Chew Weng
    Chaivichi, Phannita
    Sooksiri, Mokhapoom
    Yanakam, Sujittra
    Maneewong, Sattabongkoch
    Suriyaphol, Gunnaporn
    RESEARCH IN VETERINARY SCIENCE, 2023, 165
  • [44] Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression
    Hosseinkhan, N.
    Honardoost, M.
    Blighe, K.
    Moore, C. B. T.
    Khamseh, M. E.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (07) : 911 - 923
  • [45] PROTEOMICS ANALYSIS OF CLEAR CELL RENAL CELL CARCINOMA : IDENTIFICATION OF POTENTIAL TUMOR MARKERS
    Sun Chuanyang
    Li Jinmei
    Sun Wei
    Hou Chuansheng
    Zhang Liang
    PROGRESS ON POST-GENOME TECHNOLOGIES AND MODERN NATURAL PRODUCTS, 2011, 2011, : 202 - 204
  • [46] Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression
    N. Hosseinkhan
    M. Honardoost
    K. Blighe
    C. B. T. Moore
    M. E. Khamseh
    Journal of Endocrinological Investigation, 2020, 43 : 911 - 923
  • [47] Analysis of laser-microdissected prostate cancer tissues reveals potential tumor markers
    Shaikhibrahim, Zaki
    Lindstrot, Andreas
    Buettner, Reinhard
    Wernert, Nicolas
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 (04) : 605 - 611
  • [48] Proteomic analysis of clear cell renal cell carcinoma Identification of potential tumor markers
    Sun, Chuan Y.
    Zang, Ya C.
    San, Yu X.
    Sun, Wei
    Zhang, Liang
    SAUDI MEDICAL JOURNAL, 2010, 31 (05) : 525 - 532
  • [49] Biological variation of tumor markers and its application in the detection of disease progression in patients with non-small cell lung cancer
    Trapé, J
    de Olaguer, JP
    Buxó, J
    López, L
    CLINICAL CHEMISTRY, 2005, 51 (01) : 219 - 222
  • [50] Temporal Molecular and Biological Assessment of an Erlotinib-Resistant Lung Adenocarcinoma Model Reveals Markers of Tumor Progression and Treatment Response
    Weaver, Zoe
    Difilippantonio, Simone
    Carretero, Julian
    Martin, Philip L.
    El Meskini, Rajaa
    Iacovelli, Anthony J.
    Gumprecht, Michelle
    Kulaga, Alan
    Guerin, Theresa
    Schlomer, Jerome
    Baran, Maureen
    Kozlov, Serguei
    McCann, Thomas
    Mena, Salvador
    Al-Shahrour, Fatima
    Alexander, Danny
    Wong, Kwok-Kin
    Van Dyke, Terry
    CANCER RESEARCH, 2012, 72 (22) : 5921 - 5933